Evaxion Biotech A/S (EVAX) Financials

$2.77

$0.2 (-6.73%)
Last update: 04:00 PM EST
Day's range
$2.75
Day's range
$2.93
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25MEarning201820182019201920202020202120212022202220232023202420240%0%-10000%-10000%-20000%-20000%-30000%-30000%-40000%-40000%-50000%-50000%-60000%-60000%Profit Margin
Profit Margin
Revenue
Earnings

EVAX Income statement / Annual

Last year (2024), Evaxion Biotech A/S's total revenue was $3.34 M, an increase of 4,480.82% from the previous year. In 2024, Evaxion Biotech A/S's net income was -$10.57 M. See Evaxion Biotech A/S,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Operating Revenue $3.34 M $73.00 K $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $112.00 $571.32 K $343.45 K $105.72 K $80.98 K $73.93 K
Gross Profit $3.34 M $72.89 K -$571.32 K -$343.45 K -$105.72 K -$80.98 K -$73.93 K
Gross Profit Ratio 1 1 0 0 0 0 0
Research and Development Expenses $10.46 M $11.92 M $17.06 M $19.58 M $10.90 M $8.22 M $3.73 M
General & Administrative Expenses $7.32 M $10.35 M $8.21 M $6.25 M $5.67 M $2.63 M $1.88 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $7.32 M $10.35 M $8.21 M $6.25 M $5.67 M $2.63 M $1.88 M
Other Expenses $302.00 K $0.00 $0.00 $0.00 $0.00 $16.00 K $15.00 K
Operating Expenses $18.08 M $22.25 M $25.26 M $25.83 M $16.57 M $10.86 M $5.63 M
Cost And Expenses $18.08 M $22.27 M $25.26 M $25.83 M $16.57 M $10.86 M $5.63 M
Interest Income $254.00 K $154.00 K $2.83 M $2.04 M $216.00 K $9.00 K $2.00 K
Interest Expense $962.00 K $897.00 K $1.51 M $915.00 K $223.00 K $1.22 M $698.00 K
Depreciation & Amortization $607.02 K $615.95 K $571.32 K $343.45 K $105.72 K $80.98 K $73.93 K
EBITDA -$9.77 M -$21.40 M -$22.58 M -$24.17 M -$16.46 M -$11.90 M -$6.18 M
EBITDA Ratio -2.92 -293.19 0 0 0 0 0
Operating Income Ratio -4.41 -304.07 0 0 0 0 0
Total Other Income/Expenses Net $3.38 M -$718.00 K $1.32 M $1.12 M -$7.00 K -$1.16 M -$636.93 K
Income Before Tax -$11.36 M -$22.92 M -$23.94 M -$24.71 M -$16.58 M -$12.02 M -$6.27 M
Income Before Tax Ratio -3.4 -313.9 0 0 0 0 0
Income Tax Expense -$788.00 K -$791.22 K -$772.00 K -$178.00 K -$1.56 M -$825.00 K -$735.00 K
Net Income -$10.57 M -$22.13 M -$23.17 M -$24.53 M -$15.02 M -$11.20 M -$5.54 M
Net Income Ratio -3.16 -303.08 0 0 0 0 0
EPS -10 -32.44 -39.2 -50.32 -37.08 -27.64 -11.52
EPS Diluted -10 -32.44 -39.2 -50.32 -37.08 -27.64 -11.52
Weighted Average Shares Out $1.07 M $683.40 K $590.97 K $487.33 K $404.97 K $404.97 K $479.97 K
Weighted Average Shares Out Diluted $1.07 M $683.40 K $590.97 K $487.33 K $404.97 K $404.97 K $479.97 K
Link